BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
CYP51
,
T cell differentiation
,
HIV infection
,
Pancreas
,
Alcohol
,
Doxorubicin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Adrenergic beta- 1 Receptor
Summary
General Info
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Broad Connectivity Map (CMAP 2.0) compound database
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
The common Arg389gly ADRB1 polymorphism affects heart rate response to the ultra-short-acting β(1) a…
Epac1 participates in β1-adrenoreceptor autoantibody-mediated decreased autophagic flux in cardiomyo…
The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor.
β(1)-Adrenergic receptor gene polymorphisms and the acute response to atenolol in healthy young Japa…
ADRB1 variants in atrial fibrillation: small steps and giant leaps toward personalized therapy in ca…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Association Between Genetic Polymorphism of Beta-adrenergic Receptor and Effects of Bisoprolol in Ko…
A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Hea…
POTS Adrenergic Ab (CIHR Aims #1&2)
Acute Asthma Responsiveness and B2 Adrenergic Receptors Polymorphisms
Pulse Reduction On Beta-blocker and Ivabradine Therapy
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ